CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 6 incoming connections
- PositionOperating margin is -1.2%, lower than 95% of its Pharmaceutical Retailers peers (median 4%)
- FinancialsAltman Z-Score 3.54: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.73%Below 5Y avg (1.19%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
94.8%High
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.43BCNY363.12M · vs all stocks (USD)
Trailing P/E
33.68xvs Pharmaceutical Retailers peers
Revenue (TTM)
2.12BCNY315.86M · vs all stocks (USD)
Profit Margin
3.30%vs Pharmaceutical Retailers peers
Beta
0.3760xvs all stocks
52-Week Change
-22.08%vs all stocks
Market Capitalization
2.43BCNY363.12M · vs all stocks (USD)
Enterprise Value
2.08BCNY310.47M · vs all stocks (USD)
Trailing P/E
33.68xvs Pharmaceutical Retailers peers
Price to Sales (TTM)
1.10xvs Pharmaceutical Retailers peers
Price to Book (MRQ)
2.08xvs Pharmaceutical Retailers peers
Enterprise to Revenue
0.9830xvs Pharmaceutical Retailers peers
Gross Margin
14.69%vs Pharmaceutical Retailers peers
Profit Margin
3.30%vs Pharmaceutical Retailers peers
Operating Margin
-1.22%vs Pharmaceutical Retailers peers
Return on Assets (TTM)
-0.41%vs Pharmaceutical Retailers peers
Return on Equity (TTM)
6.30%vs Pharmaceutical Retailers peers
Revenue (TTM)
2.12BCNY315.86M · vs all stocks (USD)
Revenue per Share (TTM)
9.52CNYUpdated Sep 22, 2026Quarterly Revenue Growth
0.90%vs Pharmaceutical Retailers peers
Gross Profit (TTM)
325.15MCNY48.55M · vs all stocks (USD)
EBITDA (TTM)
29.97MCNY4.48M · vs all stocks (USD)
Net Income (TTM)
69.89MCNY10.44M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-68.70%vs Pharmaceutical Retailers peers
Operating Cash Flow (TTM)
54.72MCNY8.17M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
11.53MCNY1.72M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0780CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
0.73%vs all stocks
5-Year Average Dividend Yield
1.19%vs all stocks
Payout Ratio
94.78%vs Pharmaceutical Retailers peers
Minority Interest (Equity)
9.58MCNYFY2025 · Dec 31, 2025Revenue
2.13BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.79BCNYFY2025 · Dec 31, 2025Gross Profit
341.50MCNYFY2025 · Dec 31, 2025Operating Income
8.51MCNY1.27M · vs all stocks (USD)
Pre-tax Income
76.05MCNYFY2025 · Dec 31, 2025Income Tax Expense
17.51MCNYFY2025 · Dec 31, 2025Net Income
58.54MCNYFY2025 · Dec 31, 2025EBIT
80.56MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
102.38MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
68.32MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.10MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
14.01MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
4.51MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
222.10MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
222.10MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
58.54MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-789.11KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
21.20MCNYFY2025 · Dec 31, 2025Free Cash Flow
-13.71MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
322.52MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
58.54MCNYFY2025 · Dec 31, 2025Other Non-cash Items
12.98MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-27.82MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-22.50MCNYFY2025 · Dec 31, 2025Capital Expenditures
34.91MCNYFY2025 · Dec 31, 2025Purchase of Investments
-433.03MCNYFY2025 · Dec 31, 2025Sale of Investments
362.34MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-35.78MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
99.29MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-144.28MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-50.79MCNYFY2025 · Dec 31, 2025Other Financing Charges
-62.39MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-158.17MCNYFY2025 · Dec 31, 2025Shares Outstanding
223.09MSharesUpdated Sep 22, 2026Float Shares
104.56MSharesUpdated Sep 22, 2026% Held by Insiders
52.38%vs all stocks
% Held by Institutions
2.62%vs all stocks
Total Cash (MRQ)
401.33MCNY59.93M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.80CNYUpdated Sep 22, 2026Total Debt (MRQ)
141.51MCNY21.13M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1252xvs Pharmaceutical Retailers peers
Current Ratio (MRQ)
1.67xvs Pharmaceutical Retailers peers
Book Value per Share (MRQ)
5.02CNYUpdated Sep 22, 2026Total Assets
2.02BCNY301.84M · vs all stocks (USD)
Total Current Assets
1.06BCNYFY2025 · Dec 31, 2025Total Liabilities
850.46MCNYFY2025 · Dec 31, 2025Total Non-current Assets
964.30MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
183.97MCNYFY2025 · Dec 31, 2025Total Current Liabilities
666.49MCNYFY2025 · Dec 31, 2025Cash
95.77MCNYFY2025 · Dec 31, 2025Cash Equivalents
226.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
322.59MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.03MCNYFY2025 · Dec 31, 2025Accounts Receivable
188.59MCNYFY2025 · Dec 31, 2025Inventory
354.94MCNYFY2025 · Dec 31, 2025Accounts Payable
454.10MCNYFY2025 · Dec 31, 2025Short-term Debt
113.85MCNYFY2025 · Dec 31, 2025Other Current Liabilities
952.24KCNYFY2025 · Dec 31, 2025Long-term Debt
107.82MCNYFY2025 · Dec 31, 2025Common Stock (Book)
223.09MCNYFY2025 · Dec 31, 2025Retained Earnings
583.29MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.17BCNY174.84M · vs all stocks (USD)
52-Week Low
8.83CNYUpdated Sep 22, 202652-Week High
15.55CNYUpdated Sep 22, 202652-Week Change
-22.08%vs all stocks
Beta
0.3760xvs all stocks
50-Day MA
10.43CNYUpdated Sep 22, 2026200-Day MA
11.59CNYUpdated Sep 22, 2026Avg 10-Day Volume
4.69MSharesUpdated Sep 22, 2026Avg 30-Day Volume
11.99MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.3100CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -1.2%, lower than 95% of its Pharmaceutical Retailers peers (median 4%)Significant
Operating margin: -0.01Industry median: 0.04Industry P5: -0.01Peers compared: 21.00
Debt-to-equity is 0.13×, lower than 95% of its Pharmaceutical Retailers peers (median 0.72×)Notable
Debt-to-equity: 0.13Industry median: 0.72Industry P5: 0.18Peers compared: 21.00
Financial Health
Altman Z-Score 3.54: safe zoneNotable
Altman Z-Score: 3.54
Supply Chain
Midstream position: 5 outgoing, 6 incoming connectionsNotable
Outgoing: 5.00Incoming: 6.00
High connectivity hub: 11 industry connectionsNotable
Total Connections: 11.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Yunnan Jianzhi Health Chain Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRule
Retail Partners Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
Shoe Carnival Inc.
Tier 1FlowUnit ReplicationRiskInterface
Genesco Inc.
Tier 1FlowUnit ReplicationRiskInterface
Vertu Motors plc
Tier 1FlowUnit ReplicationInterfaceRisk
Sichuan Hezong Medicine Co., Ltd.
Tier 1FlowUnit ReplicationProductionInterface
VT Holdings Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceRisk
PTG Energy Public Company Limited
Tier 1FlowUnit ReplicationInterfaceProduction
Ministop Co., Ltd.
Tier 1FlowUnit ReplicationInterfaceProduction
Camping World Holdings Inc.
Tier 1FlowUnit ReplicationInterfaceRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Tianjin Lvyin Landscape Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Poly Plastic Masterbatch Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Mueller Industries Inc.
1 interpretationLow-Leverage Liquidity Configuration